Video

Lung Cancer Survivor Urges Others to Participate in Research, Says it ‘Will Make a Difference in the Future’ of Others

Author(s):

A breast cancer research nurse and lung cancer survivor stresses the importance of participating in clinical trials that are investigating the latest treatments.

When Alesha Arnold was diagnosed with lung cancer, she says she felt “completely blindsided,” but then turned those feelings into advocacy through sharing her story and encouraging others to participate in cancer research.

Arnold, who was honored for her contributions to the community at CURE®’s third annual Lung Cancer Heroes® awards ceremony, is a breast cancer research nurse, who has witnessed how the latest trials and studies have improved the world of cancer care.

“The things that we are doing today will make a difference in the future of people tomorrow,” Arnold said in an interview with CURE®. “We have things like immunotherapies and targeted therapies and all kinds of new advanced treatments, which have come forth through research.”

Transcript

When I was diagnosed, I completely felt like I was blindsided, because I was a relatively healthy person lived a healthy lifestyle, and then you get this diagnosis that you have advanced-stage lung cancer, it kind of changes your whole perception on your life and the life of others.

So what I wanted to do at that time, is give back and share my story with others so that maybe other people can get help they need earlier in their journey, be able to find answers, as well as encourage people to be involved with research, because research matters and it makes a difference.

The things that we are doing today will make a difference in the future of people tomorrow. We have things like immunotherapies and targeted therapies and all kinds of new advanced treatment, which have forth through research. So it's important that we stress that people participate and be a part of that research, and just to make a difference in the future.

Lung Cancer Hero® Alesha Arnold passed away on Feb. 5, 2023, leaving behind a legacy of advocacy, education and awareness in the cancer community.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.